News
But Novo Nordisk, the Danish pharma large behind the ‘miracle’ drug, has already admitted that just a ‘proportion’ of already limited stock might be shared with the health service, with the rest allotted to non-public corporations. Experts hit out at the move, arguing that ‘would not make sense’ and can leave those most in want … Read More “Stories From Cbs News HealthwatchHealth News” »